The association between SETD2 (SET Domain Containing 2, Histone Lysine Methyltransferase) and Renal Cell Carcinoma is reported, with clinical genetic testing available.
Sources1
Clinical variants0
Symptoms1
Compounds0
Trials0
Publications9
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.